- Home
- Publications
- Publication Search
- Publication Details
Title
Antifungal Resistance: An Emerging Reality and A Global Challenge
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 216, Issue suppl_3, Pages S431-S435
Publisher
Oxford University Press (OUP)
Online
2017-04-11
DOI
10.1093/infdis/jix179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents
- (2016) Miao Zhao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2016) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- The development of fluconazole resistance in Candida albicans – an example of microevolution of a fungal pathogen
- (2016) Joachim Morschhäuser JOURNAL OF MICROBIOLOGY
- Performance evaluation of multiplex PCR including Aspergillus—not so simple!: Table 1.
- (2016) Alexandre Alanio et al. MEDICAL MYCOLOGY
- The anti-Aspergillusdrug pipeline: Is the glass half full or empty?: Table 1.
- (2016) Nir Osherov et al. MEDICAL MYCOLOGY
- The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds
- (2016) Ana Espinel-Ingroff et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
- (2016) Kelley R. Healey et al. Nature Communications
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
- (2015) Paul E. Verweij et al. CLINICAL INFECTIOUS DISEASES
- Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
- (2015) Eric Delarze et al. DRUG RESISTANCE UPDATES
- The bacteriome-mycobiome interaction and antifungal host defense
- (2014) Jaap ten Oever et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antifungal drug resistance evoked via RNAi-dependent epimutations
- (2014) Silvia Calo et al. NATURE
- Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study
- (2013) Russell E. Lewis et al. MYCOSES
- The impact of azole resistance on aspergillosis guidelines
- (2012) Sarah P. Georgiadou et al. Annals of the New York Academy of Sciences
- The Composition of the Culture Medium Influences the β-1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of β-1,3-Glucan Synthesis
- (2012) Cécile Clavaud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
- (2012) Russell E. Lewis et al. Virulence
- Resistance to echinocandins comes at a cost
- (2012) Ronen Ben-Ami et al. Virulence
- The case for antifungal stewardship
- (2011) Michelle R. Ananda-Rajah et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Antifungal drug resistance: do molecular methods provide a way forward?
- (2009) David S Perlin CURRENT OPINION IN INFECTIOUS DISEASES
- Infections Caused by Scedosporium spp.
- (2008) K. J. Cortez et al. CLINICAL MICROBIOLOGY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More